United Capital Financial Advisors LLC Trims Stock Position in Relx Plc (NYSE:RELX)

United Capital Financial Advisors LLC cut its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 4.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 136,316 shares of the technology company's stock after selling 6,734 shares during the period. United Capital Financial Advisors LLC's holdings in Relx were worth $6,191,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of RELX. Private Trust Co. NA grew its position in shares of Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after purchasing an additional 199 shares in the last quarter. Sage Mountain Advisors LLC grew its holdings in shares of Relx by 5.1% during the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock worth $240,000 after purchasing an additional 258 shares in the last quarter. DRW Securities LLC increased its position in shares of Relx by 5.9% in the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock worth $211,000 after purchasing an additional 259 shares during the last quarter. Peapack Gladstone Financial Corp raised its stake in Relx by 5.7% in the third quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company's stock valued at $234,000 after purchasing an additional 267 shares in the last quarter. Finally, Marks Group Wealth Management Inc lifted its position in Relx by 1.3% during the fourth quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company's stock valued at $1,190,000 after purchasing an additional 325 shares during the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on RELX. The Goldman Sachs Group assumed coverage on shares of Relx in a report on Wednesday, March 26th. They set a "buy" rating for the company. Redburn Atlantic initiated coverage on Relx in a research report on Wednesday, January 8th. They set a "buy" rating on the stock. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Finally, StockNews.com lowered shares of Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Buy".

Relx Trading Up 1.0 %

RELX stock traded up $0.52 during trading on Tuesday, hitting $52.59. 347,670 shares of the company traded hands, compared to its average volume of 670,029. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company has a 50-day moving average of $49.39 and a 200-day moving average of $48.06. The firm has a market capitalization of $97.33 billion, a PE ratio of 28.28, a P/E/G ratio of 2.73 and a beta of 0.84. Relx Plc has a 1 year low of $40.25 and a 1 year high of $52.86.

Relx Increases Dividend

The company also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be issued a $0.5586 dividend. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. This is a positive change from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio (DPR) is 59.68%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.